EP300 and non-small cell lung carcinoma: This study identified the EP300-AS1-PTBP1-PRMT5 axis as a critical regulator of NSCLC growth and metastasis, highlighting the clinical relevance of EP300-AS1 in NSCLC (Fig. 7f).